Beam Therapeutics recently reported additional safety and efficacy data from its BEACON Phase 1/2 trial of ristoglogene autogetemcel (risto-cel) for sickle cell disease, highlighting efficient ex vivo ...

New data on Galaxy AI photo editing usage reveals 74% of users skip Generative Edit, despite noticing photo flaws. Why the ...

Foxit PDF Editor offers a powerful PDF editing software experience. It comes with numerous tools to ease the workflow of any ...

Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF ...

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...

Beam's broad early-stage pipeline and recent study progress take center stage as investors weigh its potential against rival NTLA's prospects.

Vero Beach based Indian River County Commission must address sheriff budget. Nixing data center big loss for St Lucie County, ...

Gateway Commercial Finance offers a 10-step guide for CFOs to enhance payment and data security, especially amid holiday fraud spikes.

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...

The goal is to have robots that learn and improve through practical use. This is similar to how humans develop “physical ...

LOS ANGELES, Nov. 11, 2025 /PRNewswire/ -- After years of confidential development — and fresh off an exclusive Deadline report on Nov. 10 — TACHI AI, a pioneering AI startup founded by filmmakers, ...